#bloodthinner

https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-blood-thinning-medication-children

Unfractionated heparin (UFH) is a widely used anticoagulant medication that plays a crucial role in the prevention and treatment of thrombotic disorders. This article aims to provide a comprehensive overview of UFH, its properties, uses, and market dynamics. What is Unfractionated Heparin? Unfractionated Heparin is a naturally occurring glycosaminoglycan derived from porcine intestinal mucosa or bovine lung tissue. It is a heterogeneous mixture of polysaccharide chains with varying molecular weights, typically ranging from 3,000 to 30,000 daltons. UFH exerts its anticoagulant effect by binding to antithrombin III (ATIII), which enhances the inhibition of several coagulation factors, including thrombin (factor IIa) and factor Xa.

Managing blood thinners is a crucial aspect of healthcare for individuals with conditions such as atrial fibrillation, deep vein thrombosis, or those with mechanical heart valves. Blood thinners, also known as anticoagulants, prevent blood clots but require careful monitoring to ensure they are both safe and effective. The CoaguChek Monitor plays a pivotal role in this process, offering patients a convenient and accurate way to manage their treatment. In this blog, we will explore the role of the CoaguChek Monitor in managing blood thinners, highlighting its benefits, usage, and impact on patient care.

Understanding Blood Thinners and the Need for Monitoring

Blood thinners, including warfarin and newer anticoagulants, reduce the blood's ability to clot. While this can prevent serious conditions such as strokes and pulmonary embolisms, it also increases the risk of excessive bleeding. Therefore, patients on blood thinners need regular monitoring to ensure their blood's clotting ability, measured by the International Normalized Ratio (INR), remains within a safe range.

Traditional monitoring methods often involve frequent visits to a healthcare facility for blood tests, which can be inconvenient and stressful for patients. This is where the CoaguChek Monitor becomes invaluable.

What is the CoaguChek Monitor?

The CoaguChek Monitor is a portable device that allows patients to measure their INR levels at home. It is designed to provide quick and accurate readings, enabling patients and healthcare providers to make timely adjustments to medication dosages if necessary. The device uses a small blood sample, typically obtained via a finger prick, and provides results within minutes.

Benefits of the CoaguChek Monitor in Managing Blood Thinners

. Convenience and Comfort: The CoaguChek Monitor offers unparalleled convenience by allowing patients to conduct INR tests at home or on the go. This eliminates the need for frequent trips to the clinic, saving time and reducing the burden on both patients and healthcare systems.

. Empowerment and Independence: With the CoaguChek Monitor, patients gain greater control over their health. This empowerment encourages adherence to treatment plans and fosters a proactive approach to managing their condition. Being able to monitor their INR levels independently also enhances patients' understanding of their treatment and its effects.

. Timely Adjustments: Regular monitoring with the CoaguChek Monitor enables prompt adjustments to blood thinner dosages, which is crucial for maintaining the desired INR range. This timely intervention can prevent complications associated with too high or too low INR levels, such as bleeding or clotting events.

. Improved Quality of Life: By reducing the need for frequent clinic visits and allowing for more consistent monitoring, the CoaguChek Monitor can significantly improve the quality of life for patients. This is especially beneficial for those with mobility issues or those living in remote areas.

How to Use the CoaguChek Monitor

Using the CoaguChek Monitor is straightforward. After a brief training session, patients can easily use the device at home. The process involves:

. Preparing the Device: Turn on the CoaguChek Monitor and insert a test strip.

. Obtaining a Blood Sample: Use a lancet to prick the finger and collect a small blood sample.

.  Applying the Sample: Place the blood sample on the test strip.

. Reading the Results: The device displays the INR result within a few minutes.

These results can be recorded and shared with healthcare providers, allowing for continuous monitoring and care adjustments.

The CoaguChek Monitor and PatientSelfTesting

National Nutrition Professional Supplement Reviews with Leading Health Expert Karlene Karst.

Karlene gives us a 3-minute professional supplement review on Nattokinase, an enzyme that comes from Natto a fermented soybean dish that was created in Japan. Nattokinase has been found to be an effective blood thinner and anticoagulant agent.

To learn more about Nattokinase and how to supplement with it, click here:

Nattokinase has been shown to have pro-fibrinolytic properties. Fibrinogen plays a key role in the blood clotting cascade (I like the analogy of fibrinogen being the glue that holds the clot together). Anything that breaks down fibrinogen is then also helping to break down the clot itself. Nattokinase has also been shown to increase the body's own TPA (Tissue Plasminogen Activity), thereby increasing the efficiency of the body's own clot destroying superpower, plasmin...

National Nutrition Professional Supplement Reviews with Leading Health Expert Karlene Karst.

Karlene gives us a 3-minute professional supplement review on Nattokinase, an enzyme that comes from Natto a fermented soybean dish that was created in Japan. Nattokinase has been found to be an effective blood thinner and anticoagulant agent.

To learn more about Nattokinase and how to supplement with it, click here: https://www.nationalnutrition.ca/articles/supplements/nattokinase/

Nattokinase has been shown to have pro-fibrinolytic properties. Fibrinogen plays a key role in the blood clotting cascade (I like the analogy of fibrinogen being the glue that holds the clot together). Anything that breaks down fibrinogen is then also helping to break down the clot itself. Nattokinase has also been shown to increase the body's own TPA (Tissue Plasminogen Activity), thereby increasing the efficiency of the body's own clot destroying superpower, plasmin...